{"altmetric_id":20798251,"counts":{"readers":{"mendeley":46,"citeulike":0,"connotea":0},"total":{"posts_count":121},"news":{"unique_users_count":4,"unique_users":["the_asco_post","ubm_medica","medscape","ecancer"],"posts_count":7},"twitter":{"unique_users_count":86,"unique_users":["ASCO","JCO_ASCO","oncoforecasting","OncShahab","ClinicalBriefs","DrHBurstein","HCResearcher","mtmdphd","jrgralow","MCristofanill","awolff","ChandlerParkMD","DrKynast","JoshMessi19","BetteDavisWise","LoisTeston","CI4CC","oncologypulse","GerrySkailes","lisamor2","thecancergeek","pedrazosfroilan","BDawson77","Boston_Biotech","LillyPad","AspenDoctor","MarcoBiotech","benmradyousra","PaolaMunforte","soniaujupan","CarlottaB","ONKOSconsulting","MetastaticOdds","esteban_nogales","JackRaph","ohamido","Eninnaej","PinkCasually","jamecancerdoc","JA_Helou","Icro_Meattini","OncInfo","dr_alhashem","Silviastilly","BCRFMarc","dianeradfordmd","VCCLibrary","Annlkf","Dra_Guaripete","naborala","FarmaOnco","SamanthaHecht","Massalcolombia","CultPerfectMoms","Sorena997","Helen_Flint_","GlopesMd","DrShen_YY","OncoHebdo","leninfapal","soniacuyer","NospmasD","RicevutoEnrico","desireeheadley","ahonala","nycdoc29","CancerWallonia","hoosierdfh","DrHedrick","pam65230529","CTruica","DrChoueiri","onco_pedia","FabioSchutz78","g_develasco","Pharma_Sharma","NatRevClinOncol","Kev_Levine","urbano_anido","srigsri23","markus_warmuth","oncologiaaf","DrRiadYounes","RicardoCaponero","MOCBrasil","fmedinacunha"],"posts_count":112},"facebook":{"unique_users_count":2,"unique_users":["458120690986504","134779230009524"],"posts_count":2}},"selected_quotes":["Dr. George Sledge's MONARCH 2 study update has been published as a full Original Report in JCO","Abemaciclib plus fulvestrant achieved a 48% ORR in patients w\/ measurable disease. Read the Original Report","Data from Dr. George Sledge's #ASCO17 MONARCH 2 presentation now","JCO proud to publish Dr. Sledge's MONARCH 2 study presented at ASCO Annual Meeting. Reprints gone!","#ASC017 #BreakingNews This study puts #Abemaciclib w\/ #Fulvestrant in the next NCCN guidelines for breast cancer."],"citation":{"abstract":"Purpose MONARCH 2 ( ClinicalTrials.gov identifier: NCT02107703) compared the efficacy and safety of abemaciclib, a selective cyclin-dependent kinase 4 and 6 inhibitor, plus fulvestrant with fulvestrant alone in patients with advanced breast cancer (ABC). Patients and Methods MONARCH 2 was a global, double-blind, phase III study of women with hormone receptor-positive and human epidermal growth factor receptor 2-negative ABC who had progressed while receiving neoadjuvant or adjuvant endocrine therapy (ET), \u2264 12 months from the end of adjuvant ET, or while receiving first-line ET for metastatic disease. Patients were randomly assigned 2:1 to receive abemaciclib or placebo (150 mg twice daily) on a continuous schedule and fulvestrant (500 mg, per label). The primary end point was investigator-assessed progression-free survival (PFS), and key secondary end points included overall survival, objective response rate (ORR), duration of response, clinical benefit rate, quality of life, and safety. Results Between August 2014 and December 2015, 669 patients were randomly assigned to receive abemaciclib plus fulvestrant (n = 446) or placebo plus fulvestrant (n = 223). Abemaciclib plus fulvestrant significantly extended PFS versus fulvestrant alone (median, 16.4 v 9.3 months; hazard ratio, 0.553; 95% CI, 0.449 to 0.681; P < .001). In patients with measurable disease, abemaciclib plus fulvestrant achieved an ORR of 48.1% (95% CI, 42.6% to 53.6%) compared with 21.3% (95% CI, 15.1% to 27.6%) in the control arm. The most common adverse events in the abemaciclib versus placebo arms were diarrhea (86.4% v 24.7%), neutropenia (46.0% v 4.0%), nausea (45.1% v 22.9%), and fatigue (39.9% v 26.9%). Conclusions Abemaciclib at 150 mg twice daily plus fulvestrant was effective, significantly improving PFS and ORR and demonstrating a tolerable safety profile in women with hormone receptor-positive and human epidermal growth factor receptor 2-negative ABC who progressed while receiving ET.","altmetric_jid":"4f6fa5e93cf058f610005a18","authors":["George W. Sledge, Jr.","Masakazu Toi","Patrick Neven","Joohyuk Sohn","Kenichi Inoue","Xavier Pivot","Olga Burdaeva","Meena Okera","Norikazu Masuda","Peter A. Kaufman","Han Koh","Eva-Maria Grischke","Martin Frenzel","Yong Lin","Susana Barriga","Ian C. Smith","Nawel Bourayou","Antonio Llombart-Cussac"],"doi":"10.1200\/jco.2017.73.7585","first_seen_on":"2017-06-03T18:15:23+00:00","funders":["niehs"],"handles":[],"issns":["0732-183X","1527-7755"],"journal":"Journal of Clinical Oncology","last_mentioned_on":1504369565,"links":["http:\/\/ascopubs.org\/doi\/abs\/10.1200\/JCO.2017.73.7585","http:\/\/ascopubs.org\/doi\/full\/10.1200%2FJCO.2017.73.7585?green-bar#.WTL9vTo81bE.twitter","http:\/\/ascopubs.org\/doi\/abs\/10.1200\/JCO.2017.73.7585?et_cid=39312303&et_rid=931316574&linkid=MONARCH+2%3A+Abemaciclib+in+Combination+With+Fulvestrant+in+Women+With+HR%2B%2FHER2%E2%80%93+Advanced+Breast+Cancer+Who+Had+Progressed+While+Receiving+Endocrine+Therapy+&","http:\/\/ascopubs.org\/doi\/full\/10.1200%2FJCO.2017.73.7585?green-bar#.WTMQO4Kb7zk.twitter","http:\/\/ascopubs.org\/doi\/abs\/10.1200\/JCO.2017.73.7585?af=R","http:\/\/ascopubs.org\/doi\/abs\/10.1200\/JCO.2017.73.7585#.WTUUs4oauAw.twitter","http:\/\/ascopubs.org\/doi\/abs\/10.1200\/JCO.2017.73.7585#.WTYHxOxV2FM.facebook","http:\/\/ascopubs.org\/doi\/full\/10.1200\/JCO.2017.73.7585","http:\/\/ascopubs.org\/doi\/abs\/10.1200\/JCO.2017.73.7585#.WVc23dYEyIY.twitter","http:\/\/ascopubs.org\/doi\/abs\/10.1200\/JCO.2017.73.7585#.WXaikNQX3HQ.twitter","http:\/\/ascopubs.org\/doi\/pdf\/10.1200\/JCO.2017.73.7585","http:\/\/ascopubs.org\/doi\/10.1200\/JCO.2017.73.7585"],"pmid":"28580882","pubdate":"2017-06-06T22:04:09+00:00","publisher":"American Society of Clinical Oncology","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+\/HER2\u2212 Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/monarch-2-abemaciclib-combination-fulvestrant-women-hrher2-advanced-breast-cancer-progressed-while-r"},"altmetric_score":{"score":88.9,"score_history":{"1y":88.9,"6m":88.9,"3m":19.45,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":88.9},"context_for_score":{"all":{"total_number_of_other_articles":8461697,"mean":7.1088157534769,"rank":101487,"this_scored_higher_than_pct":98,"this_scored_higher_than":8360301,"rank_type":"exact","sample_size":8461697,"percentile":98},"similar_age_3m":{"total_number_of_other_articles":248437,"mean":12.620902960923,"rank":7015,"this_scored_higher_than_pct":97,"this_scored_higher_than":241417,"rank_type":"exact","sample_size":248437,"percentile":97},"this_journal":{"total_number_of_other_articles":8977,"mean":15.377997103387,"rank":261,"this_scored_higher_than_pct":97,"this_scored_higher_than":8716,"rank_type":"exact","sample_size":8977,"percentile":97},"similar_age_this_journal_3m":{"total_number_of_other_articles":194,"mean":43.257772020725,"rank":19,"this_scored_higher_than_pct":90,"this_scored_higher_than":175,"rank_type":"exact","sample_size":194,"percentile":90}}},"demographics":{"poster_types":{"member_of_the_public":54,"researcher":11,"practitioner":17,"science_communicator":4},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":4,"Members of the public":54,"Practitioners (doctors, other healthcare professionals)":17,"Scientists":11}},"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":2,"Researcher":15,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":6,"Student  > Postgraduate":2,"Other":9,"Student  > Master":4,"Student  > Bachelor":3,"Professor":2},"by_discipline":{"Medicine and Dentistry":29,"Chemistry":4,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":5,"Nursing and Health Professions":1,"Biochemistry, Genetics and Molecular Biology":2,"Unspecified":3,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"US":31,"GB":4,"IN":1,"CA":3,"BE":1,"IT":3,"SA":1,"EC":1,"AR":1,"ES":1,"AU":1,"BR":4},"mendeley":{"GB":1}}},"posts":{"news":[{"title":"A New Triumvirate in Estrogen Receptor\u2013Positive Metastatic Breast Cancer","url":"http:\/\/ct.moreover.com\/?a=31479454999&p=1pl&v=1&x=cPWl5orLNvIv6PcC_hfxKg","license":"public","citation_ids":[20798251,3166554,20394972,2986384,22898214,12691930,6368366],"posted_on":"2017-08-10T15:46:46+00:00","summary":"Advertisement Neil Vasan, MD, PhD Maura N. Dickler, MD THE BODY OF EVIDENCE supporting the use of cell-cycle inhibitors in combination with endocrine therapy for estrogen receptor\u2013positive metastatic breast cancer now has another agent in the\u2026","author":{"name":"The ASCO Post","url":"http:\/\/www.ascopost.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/496\/normal\/Screen_Shot_2016-02-03_at_09.24.05.png?1454491455"}},{"title":"Abemaciclib Improves Response, PFS in Endocrine-Resistant Breast Cancer","url":"http:\/\/www.cancernetwork.com\/asco-breast-cancer\/abemaciclib-improves-response-pfs-endocrine-resistant-breast-cancer","license":"public","citation_ids":[20798251],"posted_on":"2017-06-04T18:37:21+00:00","summary":"CHICAGO\u2014Adding abemaciclib to fulvestrant was associated with an improved objective response rate (ORR) and a 7-month improvement in progression-free survival (PFS) compared with placebo among patients with endocrine-resistant, HR-positive, HER2-negat\u2026","author":{"name":"UBM Medica","url":"http:\/\/mediakit.ubmmedica.com\/medical-resources","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/497\/normal\/Screen_Shot_2016-02-03_at_09.30.26.png?1454491836"}},{"title":"First Look at New CDK 4\/6 Data in Metastatic Breast Cancer","url":"http:\/\/ct.moreover.com\/?a=30807365813&p=1pl&v=1&x=bB01Bv4AErUvJq-eNaR4NQ","license":"public","citation_ids":[20798251],"posted_on":"2017-06-05T21:20:38+00:00","summary":"There have been a number of interesting breast cancer presentations at the American Society of Clinical Oncology (ASCO) annual meeting this year, including several reports of CDK 4\/6 inhibitors in patients with hormone receptor\u2013positive (HR+)\/HER2-neg\u2026","author":{"name":"Medscape","url":"http:\/\/medscape.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/055\/normal\/medscape.png?1369846939"}},{"title":"Adding Abemaciclib to Fulvestrant in Hormone Receptor\u2013Positive, HER2-Negative Breast Cancer","url":"http:\/\/ct.moreover.com\/?a=30899350152&p=1pl&v=1&x=EGSBFDz5HsLg4TPxXUVHRg","license":"public","citation_ids":[20798251],"posted_on":"2017-06-14T15:01:26+00:00","summary":"By Matthew Stenger Posted: 6\/14\/2017 9:13:17 AM Last Updated: 6\/14\/2017 9:13:17 AM Tweet this page Advertisement The addition of abemaciclib to fulvestrant significantly improved progression-free survival in women with hormone receptor\u2013positive, HER2\u2026","author":{"name":"The ASCO Post","url":"http:\/\/www.ascopost.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/496\/normal\/Screen_Shot_2016-02-03_at_09.24.05.png?1454491455"}},{"title":"Abemaciclib Plus Fulvestrant Delays Breast Cancer Progression in MONARCH 2","url":"http:\/\/ct.moreover.com\/?a=31021368127&p=1pl&v=1&x=VEQMoPKnptJx3GXGzRn3kQ","license":"public","citation_ids":[20798251],"posted_on":"2017-06-26T17:19:34+00:00","summary":"Advertisement In the treatment of metastatic estrogen receptor\u2013positive breast cancer, a highly significant 45% reduction in progression was achieved with abemaciclib, combined with fulvestrant (Faslodex), in the global phase III MONARCH 2 trial\u2026","author":{"name":"The ASCO Post","url":"http:\/\/www.ascopost.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/496\/normal\/Screen_Shot_2016-02-03_at_09.24.05.png?1454491455"}},{"title":"Last Month in Oncology with Dr. Bishal Gyawali: June 2017. ecancer","url":"http:\/\/ct.moreover.com\/?a=31051449812&p=1pl&v=1&x=TbuOEwk2TfgA5gakD72hAw","license":"public","citation_ids":[8832766,20839447,20815011,19852545,20833402,20833426,20817441,20897423,20897944,20857425,20963659,20799399,20819380,20897804,20897855,20798251,20265327,20784426,20794539,20794895,21247443],"posted_on":"2017-06-29T09:36:00+00:00","summary":"Independent ecancer blogger Dr Bishal Gyawali rounds up the latest publications in oncology.","author":{"name":"ecancer","url":"http:\/\/ecancer.org\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/075\/normal\/image.png?1369859451"}},{"title":"Abemaciclib: Another CDK 4\/6 Inhibitor for Breast Cancer","url":"http:\/\/ct.moreover.com\/?a=31316151457&p=1pl&v=1&x=TKpujkQMslVfkgaqKxJyCA","license":"public","citation_ids":[20863999,20798251],"posted_on":"2017-07-25T15:22:35+00:00","summary":"Abemaciclib (from Lilly) is heading to become the third of a new class of drugs for use in breast cancer \u2014 the cyclin-dependent kinase (CDK) 4\/6 inhibitors.","author":{"name":"Medscape","url":"http:\/\/medscape.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/055\/normal\/medscape.png?1369846939"}}],"twitter":[{"url":"http:\/\/twitter.com\/ASCO\/statuses\/871067754278920192","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-03T18:15:10+00:00","author":{"name":"ASCO","url":"http:\/\/www.asco.org","image":"https:\/\/pbs.twimg.com\/profile_images\/463779450388090880\/UsaXUpTx_normal.png","description":"ASCO is the American Society of Clinical Oncology. Making a world of difference in cancer care.","id_on_source":"ASCO","tweeter_id":"20187065","geo":{"lt":38.80484,"ln":-77.04692,"country":"US"},"followers":69184},"tweet_id":"871067754278920192"},{"url":"http:\/\/twitter.com\/JCO_ASCO\/statuses\/871067754421420033","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-03T18:15:10+00:00","author":{"name":"J Clinical Oncology","url":"http:\/\/JCO.org","image":"https:\/\/pbs.twimg.com\/profile_images\/715981880357683201\/8GMeAgKJ_normal.jpg","description":"Journal of Clinical Oncology is the authoritative resource for significant oncology research, published 3 times per month by @ASCO.","id_on_source":"JCO_ASCO","tweeter_id":"2395900849","geo":{"lt":null,"ln":null},"followers":6978},"tweet_id":"871067754421420033"},{"url":"http:\/\/twitter.com\/oncoforecasting\/statuses\/871068103475646470","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-03T18:16:34+00:00","author":{"name":"Black Swan Analysis","url":"http:\/\/www.onco-strat.com","image":"https:\/\/pbs.twimg.com\/profile_images\/874679515657773056\/nF7k6iV-_normal.jpg","description":"Sub-division of @blackswanpharma, focused on market forecast modelling for oncology healthcare markets","id_on_source":"oncoforecasting","tweeter_id":"3373714001","geo":{"lt":51.52279,"ln":-0.71986,"country":"GB"},"followers":70},"tweet_id":"871068103475646470"},{"url":"http:\/\/twitter.com\/OncShahab\/statuses\/871068170018336770","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T18:16:50+00:00","author":{"name":"Nasir Shahab MD","image":"https:\/\/pbs.twimg.com\/profile_images\/870148743286358016\/HHfQT-DV_normal.jpg","description":"Oncology","id_on_source":"OncShahab","tweeter_id":"870144867057491969","geo":{"lt":41.78586,"ln":-88.14729,"country":"US"},"followers":2},"tweet_id":"871068170018336770"},{"url":"http:\/\/twitter.com\/ClinicalBriefs\/statuses\/871068948804096001","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T18:19:55+00:00","author":{"name":"Holden Caulfield PhD","url":"http:\/\/Clinical-Briefs.com","image":"https:\/\/pbs.twimg.com\/profile_images\/779016881428688897\/TFyQGGxg_normal.jpg","description":"Indep writer @ClinicalBriefs: Medical insights, simplified\u2122. Follow for news on medical research and policy. Opinions are my own.","id_on_source":"ClinicalBriefs","tweeter_id":"3810014352","geo":{"lt":null,"ln":null},"followers":355},"tweet_id":"871068948804096001"},{"url":"http:\/\/twitter.com\/DrHBurstein\/statuses\/871069040856444929","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-03T18:20:17+00:00","author":{"name":"Hal Burstein, MD","url":"http:\/\/www.dana-farber.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/618868499423887360\/qUW4gRNl_normal.jpg","description":"Breast cancer specialist and scholar @DanaFarber Cancer Institute and @HarvardMed. Tweets are my own and not medical advice. #bcsm #mBCSM","id_on_source":"DrHBurstein","tweeter_id":"3366464453","geo":{"lt":42.35843,"ln":-71.05977,"country":"US"},"followers":2032},"tweet_id":"871069040856444929"},{"url":"http:\/\/twitter.com\/HCResearcher\/statuses\/871069070677901316","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-03T18:20:24+00:00","author":{"name":"Susan","image":"https:\/\/pbs.twimg.com\/profile_images\/2680039685\/1563bc4afb9314d487ce776c9f32822c_normal.png","id_on_source":"HCResearcher","tweeter_id":"71255309","geo":{"lt":null,"ln":null},"followers":216},"tweet_id":"871069070677901316"},{"url":"http:\/\/twitter.com\/mtmdphd\/statuses\/871069246255767552","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T18:21:06+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15409},"tweet_id":"871069246255767552"},{"url":"http:\/\/twitter.com\/jrgralow\/statuses\/871070039730008065","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-03T18:24:15+00:00","author":{"name":"Julie Gralow","url":"http:\/\/www.seattlecca.org\/doctor\/julie-r-gralow.cfm","image":"https:\/\/pbs.twimg.com\/profile_images\/2226142398\/Gralow_labcoat_4_crop_adj_normal.jpg","description":"Breast Cancer and Global Oncology Specialist, University of Washington and Seattle Cancer Care Alliance","id_on_source":"jrgralow","tweeter_id":"330036521","geo":{"lt":47.60621,"ln":-122.33207,"country":"US"},"followers":5520},"tweet_id":"871070039730008065"},{"url":"http:\/\/twitter.com\/MCristofanill\/statuses\/871071565793943552","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-03T18:30:19+00:00","author":{"name":"Massimo Cristofanill","image":"https:\/\/pbs.twimg.com\/profile_images\/811341892948357120\/XkF_1Tda_normal.jpg","description":"Associate Director for Precision Medicine and Translational Research\/Breast Medical Oncology\/IBC Research and Treatment at Northwestern's @LurieCancer","id_on_source":"MCristofanill","tweeter_id":"483253162","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":430},"tweet_id":"871071565793943552"},{"url":"http:\/\/twitter.com\/awolff\/statuses\/871071973278986244","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-03T18:31:56+00:00","author":{"name":"Antonio Wolff","url":"http:\/\/scholar.google.com\/citations?user=UR2BQW8AAAAJ&hl=en&oi=ao","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000378885249\/fc974fc24cf2a135ee3a5f07949ec1d5_normal.jpeg","description":"medical oncologist, breast cancer researcher & professor @HopkinsKimmel @HopkinsMedicine; views expressed my own. RT\/MT means interesting tweet, not endorsement","id_on_source":"awolff","tweeter_id":"14543524","geo":{"lt":39.29038,"ln":-76.61219,"country":"US"},"followers":1935},"tweet_id":"871071973278986244"},{"url":"http:\/\/twitter.com\/ChandlerParkMD\/statuses\/871075116666564608","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-03T18:44:26+00:00","author":{"name":"Chandler Park, M.D.","url":"http:\/\/ChandlerParkMD.com","image":"https:\/\/pbs.twimg.com\/profile_images\/859620347716546561\/0_m-Yi1G_normal.jpg","description":"Cancer Expert @ASCO University\ud83d\udd39Writer @Doximity\ud83d\udd39MedSchool Professor @UniversityofKy\ud83d\udd39ResidencyAdvisor @Medscape \ud83d\udd39Interviewed @Newsweek @USNews @ReadersDigest","id_on_source":"ChandlerParkMD","tweeter_id":"1145704818","geo":{"lt":38.25424,"ln":-85.75941,"country":"US"},"followers":10291},"tweet_id":"871075116666564608"},{"url":"http:\/\/twitter.com\/DrKynast\/statuses\/871076090814623745","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T18:48:18+00:00","author":{"name":"Dr.med. Bernd Kynast","image":"https:\/\/pbs.twimg.com\/profile_images\/773512285629345792\/2AmdEU5W_normal.jpg","description":"Medical Oncology, Molecular Genetics, Medical & Business Consultancy, Commander (Navy, Reserve) \u00a7 Unfollow=blocked #Passion4America","id_on_source":"DrKynast","tweeter_id":"773340859303682049","geo":{"lt":null,"ln":null},"followers":2159},"tweet_id":"871076090814623745"},{"url":"http:\/\/twitter.com\/JoshMessi19\/statuses\/871076202026381312","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T18:48:45+00:00","author":{"name":"MURALI PARAMANANDHAN","image":"https:\/\/pbs.twimg.com\/profile_images\/860447511835688960\/IAxHB1wC_normal.jpg","description":"RADIATION ONCOLOGIST, MARK 9:23 philosophy of life, CHRIST my mission, FOOTBALL my passion!!! BARCELONA FC\nfor life..!!","id_on_source":"JoshMessi19","tweeter_id":"867867128","geo":{"lt":12.97194,"ln":77.59369,"country":"IN"},"followers":123},"tweet_id":"871076202026381312"},{"url":"http:\/\/twitter.com\/BetteDavisWise\/statuses\/871076260193202176","license":"gnip","rt":["ChandlerParkMD"],"citation_ids":[20798251],"posted_on":"2017-06-03T18:48:58+00:00","author":{"name":"Bette Davis Wise","image":"https:\/\/pbs.twimg.com\/profile_images\/869029479007571968\/r3gqsqMV_normal.jpg","description":"Ignite. Inspire. Enlighten.","id_on_source":"BetteDavisWise","tweeter_id":"100419313","geo":{"lt":null,"ln":null},"followers":1119},"tweet_id":"871076260193202176"},{"url":"http:\/\/twitter.com\/LoisTeston\/statuses\/871078260737802242","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-03T18:56:55+00:00","author":{"name":"Lois J Teston MD","image":"https:\/\/pbs.twimg.com\/profile_images\/893811607628894208\/9VA_E-Y8_normal.jpg","description":"Finding a way\/ Health and Healing\/\/ My words, my thoughts only...","id_on_source":"LoisTeston","tweeter_id":"43604199","geo":{"lt":40.25034,"ln":-83.00018,"country":"US"},"followers":617},"tweet_id":"871078260737802242"},{"url":"http:\/\/twitter.com\/CI4CC\/statuses\/871079055508066305","license":"gnip","rt":["awolff"],"citation_ids":[20798251],"posted_on":"2017-06-03T19:00:05+00:00","author":{"name":"Cancer Informatics","url":"http:\/\/www.ci4cc.org","image":"https:\/\/pbs.twimg.com\/profile_images\/519531893985779714\/0hlCFW_p_normal.jpeg","description":"Cancer Informatics-for-Cancer Centers. Home for Health IT Pro's & NCI Designated Cancer Center Clinical, OMIC's, & Biomedical Informatics Academic Leaders","id_on_source":"CI4CC","tweeter_id":"1732599787","geo":{"lt":37.77493,"ln":-122.41942,"country":"US"},"followers":2586},"tweet_id":"871079055508066305"},{"url":"http:\/\/twitter.com\/oncologypulse\/statuses\/871079985964097536","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T19:03:47+00:00","author":{"name":"OncologyPulse","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","description":"Curating data + ideas to inform insights and trends","id_on_source":"oncologypulse","tweeter_id":"3019949315","geo":{"lt":null,"ln":null},"followers":7},"tweet_id":"871079985964097536"},{"url":"http:\/\/twitter.com\/GerrySkailes\/statuses\/871080893879857153","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T19:07:23+00:00","author":{"name":"Gerry Skailes","image":"https:\/\/pbs.twimg.com\/profile_images\/778331994262560768\/4gtuvTP4_normal.jpg","description":"Consultant oncologist and deputy medical director@lancashire teaching hospitals, clinical lead for cancer NW Coast SCN.","id_on_source":"GerrySkailes","tweeter_id":"778320473067294720","geo":{"lt":52.16045,"ln":-0.70312,"country":"GB"},"followers":191},"tweet_id":"871080893879857153"},{"url":"http:\/\/twitter.com\/lisamor2\/statuses\/871080982958317568","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T19:07:44+00:00","author":{"name":"Lisa M","image":"https:\/\/pbs.twimg.com\/profile_images\/871457703096463362\/rPyWjjLu_normal.jpg","description":"a thirty-something Melbournian working in cancer policy in the community sector; views my own","id_on_source":"lisamor2","tweeter_id":"342689478","geo":{"lt":null,"ln":null},"followers":129},"tweet_id":"871080982958317568"},{"url":"http:\/\/twitter.com\/thecancergeek\/statuses\/871086315512635392","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-03T19:28:56+00:00","author":{"name":"Angela Alexander","url":"http:\/\/thecancergeek.wordpress.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/430641398031740928\/Edjlb7tB_normal.jpeg","description":"#InflammatoryBreastCancer #clinicaltrials geek @ MD Anderson. #TNBC & #sarcoma interest. Patient advocacy, cancer edu volunteer. Tweets=my views only. \uf8ff fan.","id_on_source":"thecancergeek","tweeter_id":"14155350","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":2965},"tweet_id":"871086315512635392"},{"url":"http:\/\/twitter.com\/pedrazosfroilan\/statuses\/871089252121137152","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-03T19:40:36+00:00","author":{"name":"Paco Olba","image":"https:\/\/pbs.twimg.com\/profile_images\/704348675041062912\/PnyywHGW_normal.jpg","description":"Asturiano, amante de sus ra\u00edces","id_on_source":"pedrazosfroilan","tweeter_id":"2301326171","geo":{"lt":null,"ln":null},"followers":124},"tweet_id":"871089252121137152"},{"url":"http:\/\/twitter.com\/BDawson77\/statuses\/871089269644939269","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T19:40:40+00:00","author":{"name":"Beverly Dawson","image":"https:\/\/pbs.twimg.com\/profile_images\/588515709094887425\/nNlsMIb7_normal.jpg","description":"BScPharm, BCPS, PharmD. Oncology pharmacist @CHUDGLD, Moncton NB. *Married to politics* Tweets are my own.","id_on_source":"BDawson77","tweeter_id":"25904161","geo":{"lt":46.11594,"ln":-64.80186,"country":"CA"},"followers":104},"tweet_id":"871089269644939269"},{"url":"http:\/\/twitter.com\/pedrazosfroilan\/statuses\/871089529775689729","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-03T19:41:42+00:00","author":{"name":"Paco Olba","image":"https:\/\/pbs.twimg.com\/profile_images\/704348675041062912\/PnyywHGW_normal.jpg","description":"Asturiano, amante de sus ra\u00edces","id_on_source":"pedrazosfroilan","tweeter_id":"2301326171","geo":{"lt":null,"ln":null},"followers":124},"tweet_id":"871089529775689729"},{"url":"http:\/\/twitter.com\/Boston_Biotech\/statuses\/871093003871539200","license":"gnip","rt":["thecancergeek"],"citation_ids":[20798251],"posted_on":"2017-06-03T19:55:30+00:00","author":{"name":"BosBiotech","image":"https:\/\/pbs.twimg.com\/profile_images\/344513261577229392\/93973ee106911636120a3b67f706ecd6_normal.png","description":"Biotechnology and Life Sciences, Opinions are not work related","id_on_source":"Boston_Biotech","tweeter_id":"49974658","geo":{"lt":42.36565,"ln":-71.10832,"country":"US"},"followers":1402},"tweet_id":"871093003871539200"},{"url":"http:\/\/twitter.com\/LillyPad\/statuses\/871093641837785088","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T19:58:03+00:00","author":{"name":"Eli Lilly & Company","url":"http:\/\/elil.ly\/communityguidelines","image":"https:\/\/pbs.twimg.com\/profile_images\/582648545926254592\/fzNfPMnV_normal.jpg","description":"An official Twitter feed of Eli Lilly and Company. LillyPad bloggers tweet on public policy, Life at Lilly and corporate responsibility.","id_on_source":"LillyPad","tweeter_id":"172496840","geo":{"lt":null,"ln":null},"followers":102865},"tweet_id":"871093641837785088"},{"url":"http:\/\/twitter.com\/AspenDoctor\/statuses\/871097757150433280","license":"gnip","rt":["ChandlerParkMD"],"citation_ids":[20798251],"posted_on":"2017-06-03T20:14:24+00:00","author":{"name":"Larry Cage M.D.","image":"https:\/\/pbs.twimg.com\/profile_images\/891635955593089028\/djB8emCH_normal.jpg","description":"Son|Father|Surgeon|Cancer Survivor","id_on_source":"AspenDoctor","tweeter_id":"29577330","geo":{"lt":39.1911,"ln":-106.81754,"country":"US"},"followers":506},"tweet_id":"871097757150433280"},{"url":"http:\/\/twitter.com\/MarcoBiotech\/statuses\/871099612882280448","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T20:21:46+00:00","author":{"name":"Marco Biopharma Bot","url":"http:\/\/endpts.com","image":"https:\/\/pbs.twimg.com\/profile_images\/794344137235513344\/tuDDlcAV_normal.jpg","description":"I read the firehose of BioTwitter so biopharma execs don't have to. Fast trending links, mostly topical. A service from Endpoints News @endpts.","id_on_source":"MarcoBiotech","tweeter_id":"2810327237","geo":{"lt":null,"ln":null},"followers":796},"tweet_id":"871099612882280448"},{"url":"http:\/\/twitter.com\/benmradyousra\/statuses\/871104949547085824","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T20:42:58+00:00","author":{"name":"Ben mrad Yousra","image":"https:\/\/pbs.twimg.com\/profile_images\/623461016857374720\/5ITErZzv_normal.jpg","id_on_source":"benmradyousra","tweeter_id":"3027881805","geo":{"lt":null,"ln":null},"followers":29},"tweet_id":"871104949547085824"},{"url":"http:\/\/twitter.com\/PaolaMunforte\/statuses\/871109386499969025","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T21:00:36+00:00","author":{"name":"Paola","image":"https:\/\/pbs.twimg.com\/profile_images\/687205190143979520\/4gbbAQYo_normal.jpg","description":"Sono una chimica che mette le persone al centro, un'amante dell'arte poco artista, una musicista poco praticante e #ilovethisgame","id_on_source":"PaolaMunforte","tweeter_id":"4174539453","geo":{"lt":null,"ln":null},"followers":70},"tweet_id":"871109386499969025"},{"url":"http:\/\/twitter.com\/soniaujupan\/statuses\/871119659910778880","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T21:41:26+00:00","author":{"name":"sonia ujupan","image":"https:\/\/pbs.twimg.com\/profile_images\/662055938803834880\/y9I_kuAL_normal.jpg","description":"Oncology Corporate Affairs @LillyPadEU- views are my own","id_on_source":"soniaujupan","tweeter_id":"2671275675","geo":{"lt":50.85045,"ln":4.34878,"country":"BE"},"followers":130},"tweet_id":"871119659910778880"},{"url":"http:\/\/twitter.com\/CarlottaB\/statuses\/871123873907003392","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T21:58:10+00:00","author":{"name":"CarlottaB","url":"http:\/\/www.ffro.it\/","image":"https:\/\/pbs.twimg.com\/profile_images\/727979043224694784\/XGRzns0K_normal.jpg","description":"Radiation Oncology Resident at AOU Careggi - Universit\u00e0 di Firenze. AIRO, AIRB, ESTRO and ESMO member.\nSupport Firenze Radioterapia Oncologica ffro.it","id_on_source":"CarlottaB","tweeter_id":"14838008","geo":{"lt":43.41667,"ln":11,"country":"IT"},"followers":66},"tweet_id":"871123873907003392"},{"url":"http:\/\/twitter.com\/ONKOSconsulting\/statuses\/871130503885316099","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T22:24:31+00:00","author":{"name":"ONKOS Consulting","image":"https:\/\/pbs.twimg.com\/profile_images\/579978338049138688\/RqlopOAX_normal.png","id_on_source":"ONKOSconsulting","tweeter_id":"3107537152","geo":{"lt":null,"ln":null},"followers":29},"tweet_id":"871130503885316099"},{"url":"http:\/\/twitter.com\/MetastaticOdds\/statuses\/871141261574631426","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T23:07:16+00:00","author":{"name":"Theresa's Research","url":"http:\/\/theresasresearch.org","image":"https:\/\/pbs.twimg.com\/profile_images\/793495754434158593\/hL2u0ulI_normal.jpg","description":"Our mission is to specifically fund RESEARCH for metastatic breast cancer.\n\nWe host an annual medical conference for MBC.","id_on_source":"MetastaticOdds","tweeter_id":"1531633554","geo":{"lt":null,"ln":null},"followers":711},"tweet_id":"871141261574631426"},{"url":"http:\/\/twitter.com\/esteban_nogales\/statuses\/871143815209529345","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-03T23:17:25+00:00","author":{"name":"Esteban Nogales","image":"https:\/\/pbs.twimg.com\/profile_images\/875434672855162881\/SVSBc2ak_normal.jpg","id_on_source":"esteban_nogales","tweeter_id":"841043071714373632","geo":{"lt":null,"ln":null},"followers":24},"tweet_id":"871143815209529345"},{"url":"http:\/\/twitter.com\/JackRaph\/statuses\/871145701404749824","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-03T23:24:54+00:00","author":{"name":"Jacques Raphael","image":"https:\/\/pbs.twimg.com\/profile_images\/862067863787524097\/mlT3JWcP_normal.jpg","description":"Medical Oncologist, Assistant professor, University of Western Ontario, London. Tweets my own","id_on_source":"JackRaph","tweeter_id":"84117245","geo":{"lt":60.10867,"ln":-113.64258,"country":"CA"},"followers":60},"tweet_id":"871145701404749824"},{"url":"http:\/\/twitter.com\/ohamido\/statuses\/871145957773258752","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-03T23:25:56+00:00","author":{"name":"Oday Hamid","image":"https:\/\/pbs.twimg.com\/profile_images\/700840133323579392\/Qm7lLwMK_normal.jpg","description":"Father, Husband, Friend, Cancer Researcher, and U of Michigan Faithful.","id_on_source":"ohamido","tweeter_id":"62598853","geo":{"lt":39.76838,"ln":-86.15804,"country":"US"},"followers":18},"tweet_id":"871145957773258752"},{"url":"http:\/\/twitter.com\/Eninnaej\/statuses\/871188121873940480","license":"gnip","rt":["MCristofanill"],"citation_ids":[20798251],"posted_on":"2017-06-04T02:13:28+00:00","author":{"name":"Jeannine Donahue","image":"https:\/\/pbs.twimg.com\/profile_images\/704384758785163264\/cPnPXUGC_normal.jpg","description":"Philly Girl to Chi-town - My views are my own - Inflammatory Breast Cancer Survivor - OncoSET Program Coordinator at @LurieCancer - Northwestern Medicine","id_on_source":"Eninnaej","tweeter_id":"50495786","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":333},"tweet_id":"871188121873940480"},{"url":"http:\/\/twitter.com\/PinkCasually\/statuses\/871196896827772928","license":"gnip","rt":["ChandlerParkMD"],"citation_ids":[20798251],"posted_on":"2017-06-04T02:48:20+00:00","author":{"name":"Cindy King","image":"https:\/\/pbs.twimg.com\/profile_images\/868858585136193536\/A8BWVRli_normal.jpg","description":"RN\/Mom\/Daughter","id_on_source":"PinkCasually","tweeter_id":"232940433","geo":{"lt":37.98869,"ln":-84.47772,"country":"US"},"followers":24},"tweet_id":"871196896827772928"},{"url":"http:\/\/twitter.com\/jamecancerdoc\/statuses\/871212015884304385","license":"gnip","rt":["ChandlerParkMD"],"citation_ids":[20798251],"posted_on":"2017-06-04T03:48:25+00:00","author":{"name":"Jame Abraham","url":"http:\/\/my.clevelandclinic.org\/staff_directory\/staff_display?DoctorID=18395","image":"https:\/\/pbs.twimg.com\/profile_images\/756615440663797765\/g7arvfmI_normal.jpg","description":"@CleClinicMD #CleclinicBC #RealMenwearPink  #breastcancer  Tweets are mine I RT not endorsements I Contributor @USNewsHealth No act of #Kindness is ever wasted","id_on_source":"jamecancerdoc","tweeter_id":"311474165","geo":{"lt":41.4995,"ln":-81.69541,"country":"US"},"followers":5382},"tweet_id":"871212015884304385"},{"url":"http:\/\/twitter.com\/JA_Helou\/statuses\/871232613075361792","license":"gnip","rt":["JackRaph"],"citation_ids":[20798251],"posted_on":"2017-06-04T05:10:16+00:00","author":{"name":"Joelle","image":"https:\/\/pbs.twimg.com\/profile_images\/791789694988218369\/Y1ALOFx__normal.jpg","description":"Radiation Oncologist; University of Toronto Department of Radiation Oncology; Princess Margaret Cancer Centre","id_on_source":"JA_Helou","tweeter_id":"791378934181031937","geo":{"lt":43.25011,"ln":-79.84963,"country":"CA"},"followers":138},"tweet_id":"871232613075361792"},{"url":"http:\/\/twitter.com\/Icro_Meattini\/statuses\/871251391494459392","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-04T06:24:53+00:00","author":{"name":"Icro Meattini","image":"https:\/\/pbs.twimg.com\/profile_images\/863142668905451521\/GlsLBr2O_normal.jpg","description":"Consultant Clinical Oncologist, Radiation Oncology Research\/Breast Cancer Research, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Italy","id_on_source":"Icro_Meattini","tweeter_id":"861213365510778886","geo":{"lt":43.41667,"ln":11,"country":"IT"},"followers":19},"tweet_id":"871251391494459392"},{"url":"http:\/\/twitter.com\/OncInfo\/statuses\/871327912141762560","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-04T11:28:57+00:00","author":{"name":"Oncology Information","url":"http:\/\/www.oncinfo.ca","image":"https:\/\/pbs.twimg.com\/profile_images\/808392475115130880\/9mmGiVfB_normal.jpg","description":"Oncology Information is a leading service provider for digital solutions aimed at oncology health care providers worldwide","id_on_source":"OncInfo","tweeter_id":"808391089224880129","geo":{"lt":null,"ln":null},"followers":186},"tweet_id":"871327912141762560"},{"url":"http:\/\/twitter.com\/dr_alhashem\/statuses\/871360323927904256","license":"gnip","rt":["DrHBurstein"],"citation_ids":[20798251],"posted_on":"2017-06-04T13:37:44+00:00","author":{"name":"Hashem Al Hashem","image":"https:\/\/pbs.twimg.com\/profile_images\/619937411787681792\/Ht4Giz3S_normal.jpg","description":"Internist , Medical Oncologist, Medical Educator","id_on_source":"dr_alhashem","tweeter_id":"198446873","geo":{"lt":25,"ln":45,"country":"SA"},"followers":501},"tweet_id":"871360323927904256"},{"url":"http:\/\/twitter.com\/Silviastilly\/statuses\/871367381934854146","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-04T14:05:47+00:00","author":{"name":"Silvia","image":"https:\/\/pbs.twimg.com\/profile_images\/776052449501118464\/oEdYyFU__normal.jpg","id_on_source":"Silviastilly","tweeter_id":"4100025232","geo":{"lt":45.96389,"ln":12.6575,"country":"IT"},"followers":45},"tweet_id":"871367381934854146"},{"url":"http:\/\/twitter.com\/DrKynast\/statuses\/871368663491891201","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-04T14:10:53+00:00","author":{"name":"Dr.med. Bernd Kynast","image":"https:\/\/pbs.twimg.com\/profile_images\/773512285629345792\/2AmdEU5W_normal.jpg","description":"Medical Oncology, Molecular Genetics, Medical & Business Consultancy, Commander (Navy, Reserve) \u00a7 Unfollow=blocked #Passion4America","id_on_source":"DrKynast","tweeter_id":"773340859303682049","geo":{"lt":null,"ln":null},"followers":2159},"tweet_id":"871368663491891201"},{"url":"http:\/\/twitter.com\/BCRFMarc\/statuses\/871373458340552705","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-04T14:29:56+00:00","author":{"name":"Marc Hurlbert","url":"http:\/\/www.bcrfcure.org","image":"https:\/\/pbs.twimg.com\/profile_images\/797819034188189696\/iCRsiKMw_normal.jpg","description":"Chief Mission Officer, Breast Cancer Research Foundation working to end breast cancer. Advocate, pharmacologist, scientist.","id_on_source":"BCRFMarc","tweeter_id":"27862834","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":1072},"tweet_id":"871373458340552705"},{"url":"http:\/\/twitter.com\/dianeradfordmd\/statuses\/871404121320034304","license":"gnip","rt":["ChandlerParkMD"],"citation_ids":[20798251],"posted_on":"2017-06-04T16:31:47+00:00","author":{"name":"Diane Radford MD","url":"http:\/\/DianeRadfordMD.com","image":"https:\/\/pbs.twimg.com\/profile_images\/824082792300417025\/LoJdinn7_normal.jpg","description":"Staff breast surgeon @ClevelandClinic, writer, golfer. From Troon, Scotland. Author Bless Your Little Cotton Socks. Opinions my own.","id_on_source":"dianeradfordmd","tweeter_id":"280192329","geo":{"lt":41.4995,"ln":-81.69541,"country":"US"},"followers":13624},"tweet_id":"871404121320034304"},{"url":"http:\/\/twitter.com\/VCCLibrary\/statuses\/871408748019015681","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-04T16:50:10+00:00","author":{"name":"Cancer Library VCC","url":"http:\/\/www.wales.nhs.uk\/velindrelibrary","image":"https:\/\/pbs.twimg.com\/profile_images\/478464349476884480\/YlBsicot_normal.jpeg","description":"The only cancer specialist library service in Wales.  Supporting NHS and academic staff, students and health professionals throughout the Principality.","id_on_source":"VCCLibrary","tweeter_id":"1288296943","geo":{"lt":51.48,"ln":-3.18,"country":"GB"},"followers":657},"tweet_id":"871408748019015681"},{"url":"http:\/\/twitter.com\/JCO_ASCO\/statuses\/871447747102203909","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-04T19:25:08+00:00","author":{"name":"J Clinical Oncology","url":"http:\/\/JCO.org","image":"https:\/\/pbs.twimg.com\/profile_images\/715981880357683201\/8GMeAgKJ_normal.jpg","description":"Journal of Clinical Oncology is the authoritative resource for significant oncology research, published 3 times per month by @ASCO.","id_on_source":"JCO_ASCO","tweeter_id":"2395900849","geo":{"lt":null,"ln":null},"followers":6978},"tweet_id":"871447747102203909"},{"url":"http:\/\/twitter.com\/ClinicalBriefs\/statuses\/871447876089647106","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-04T19:25:39+00:00","author":{"name":"Holden Caulfield PhD","url":"http:\/\/Clinical-Briefs.com","image":"https:\/\/pbs.twimg.com\/profile_images\/779016881428688897\/TFyQGGxg_normal.jpg","description":"Indep writer @ClinicalBriefs: Medical insights, simplified\u2122. Follow for news on medical research and policy. Opinions are my own.","id_on_source":"ClinicalBriefs","tweeter_id":"3810014352","geo":{"lt":null,"ln":null},"followers":355},"tweet_id":"871447876089647106"},{"url":"http:\/\/twitter.com\/Annlkf\/statuses\/871448573757575170","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-04T19:28:25+00:00","author":{"name":"annie1408","image":"https:\/\/pbs.twimg.com\/profile_images\/857406552030015488\/5x8A5U4v_normal.jpg","id_on_source":"Annlkf","tweeter_id":"573271315","geo":{"lt":null,"ln":null},"followers":42},"tweet_id":"871448573757575170"},{"url":"http:\/\/twitter.com\/Dra_Guaripete\/statuses\/871449891511336960","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-04T19:33:39+00:00","author":{"name":"Sara Cecilia","url":"http:\/\/saraceci.wordpress.com","image":"https:\/\/pbs.twimg.com\/profile_images\/898487500372557825\/zgkK8j_L_normal.jpg","description":"#M\u00e9dicoUCV #Onc\u00f3logoUCV #MaduroDictador #TchaikovskyLieber #ALowFlyingPanickAttack #HomelandJunkie #InceptionConsultant #ARevelationInTheLightOfDay #SapereAude","id_on_source":"Dra_Guaripete","tweeter_id":"86612381","geo":{"lt":null,"ln":null},"followers":3964},"tweet_id":"871449891511336960"},{"url":"http:\/\/twitter.com\/naborala\/statuses\/871453139601326080","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-04T19:46:33+00:00","author":{"name":"Bora_Lim, MD","url":"https:\/\/www.linkedin.com\/in\/naborala","image":"https:\/\/pbs.twimg.com\/profile_images\/903963067519827969\/gjyvkGNI_normal.jpg","description":"MD Anderson Cancer Center Breast Medical Oncologist, Translational Researcher finding cure for Breast Cancer. \"tweets are my own opinion\" Born\/Educated in S KOR","id_on_source":"naborala","tweeter_id":"380808706","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":664},"tweet_id":"871453139601326080"},{"url":"http:\/\/twitter.com\/FarmaOnco\/statuses\/871457320340992002","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-04T20:03:10+00:00","author":{"name":"FarmaOnco","image":"https:\/\/pbs.twimg.com\/profile_images\/2930931336\/c5ed1efcf9ddf36d4803c1ab88604f4f_normal.jpeg","description":"Farmac\u00e9utica hospitalaria que intenta mantenerse al d\u00eda en onco, hemato y otras cosas","id_on_source":"FarmaOnco","tweeter_id":"917639060","geo":{"lt":null,"ln":null},"followers":1686},"tweet_id":"871457320340992002"},{"url":"http:\/\/twitter.com\/OncShahab\/statuses\/871457966771318784","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-04T20:05:44+00:00","author":{"name":"Nasir Shahab MD","image":"https:\/\/pbs.twimg.com\/profile_images\/870148743286358016\/HHfQT-DV_normal.jpg","description":"Oncology","id_on_source":"OncShahab","tweeter_id":"870144867057491969","geo":{"lt":41.78586,"ln":-88.14729,"country":"US"},"followers":2},"tweet_id":"871457966771318784"},{"url":"http:\/\/twitter.com\/benmradyousra\/statuses\/871495713644883968","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-04T22:35:44+00:00","author":{"name":"Ben mrad Yousra","image":"https:\/\/pbs.twimg.com\/profile_images\/623461016857374720\/5ITErZzv_normal.jpg","id_on_source":"benmradyousra","tweeter_id":"3027881805","geo":{"lt":null,"ln":null},"followers":29},"tweet_id":"871495713644883968"},{"url":"http:\/\/twitter.com\/ASCO\/statuses\/871501944208097281","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-04T23:00:29+00:00","author":{"name":"ASCO","url":"http:\/\/www.asco.org","image":"https:\/\/pbs.twimg.com\/profile_images\/463779450388090880\/UsaXUpTx_normal.png","description":"ASCO is the American Society of Clinical Oncology. Making a world of difference in cancer care.","id_on_source":"ASCO","tweeter_id":"20187065","geo":{"lt":38.80484,"ln":-77.04692,"country":"US"},"followers":69184},"tweet_id":"871501944208097281"},{"url":"http:\/\/twitter.com\/HCResearcher\/statuses\/871502301525147651","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-04T23:01:55+00:00","author":{"name":"Susan","image":"https:\/\/pbs.twimg.com\/profile_images\/2680039685\/1563bc4afb9314d487ce776c9f32822c_normal.png","id_on_source":"HCResearcher","tweeter_id":"71255309","geo":{"lt":null,"ln":null},"followers":216},"tweet_id":"871502301525147651"},{"url":"http:\/\/twitter.com\/ClinicalBriefs\/statuses\/871502575337656324","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-04T23:03:00+00:00","author":{"name":"Holden Caulfield PhD","url":"http:\/\/Clinical-Briefs.com","image":"https:\/\/pbs.twimg.com\/profile_images\/779016881428688897\/TFyQGGxg_normal.jpg","description":"Indep writer @ClinicalBriefs: Medical insights, simplified\u2122. Follow for news on medical research and policy. Opinions are my own.","id_on_source":"ClinicalBriefs","tweeter_id":"3810014352","geo":{"lt":null,"ln":null},"followers":355},"tweet_id":"871502575337656324"},{"url":"http:\/\/twitter.com\/oncoforecasting\/statuses\/871503406166364160","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-04T23:06:18+00:00","author":{"name":"Black Swan Analysis","url":"http:\/\/www.onco-strat.com","image":"https:\/\/pbs.twimg.com\/profile_images\/874679515657773056\/nF7k6iV-_normal.jpg","description":"Sub-division of @blackswanpharma, focused on market forecast modelling for oncology healthcare markets","id_on_source":"oncoforecasting","tweeter_id":"3373714001","geo":{"lt":51.52279,"ln":-0.71986,"country":"GB"},"followers":70},"tweet_id":"871503406166364160"},{"url":"http:\/\/twitter.com\/OncShahab\/statuses\/871517622789124096","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T00:02:47+00:00","author":{"name":"Nasir Shahab MD","image":"https:\/\/pbs.twimg.com\/profile_images\/870148743286358016\/HHfQT-DV_normal.jpg","description":"Oncology","id_on_source":"OncShahab","tweeter_id":"870144867057491969","geo":{"lt":41.78586,"ln":-88.14729,"country":"US"},"followers":2},"tweet_id":"871517622789124096"},{"url":"http:\/\/twitter.com\/LillyPad\/statuses\/871529513041231873","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T00:50:02+00:00","author":{"name":"Eli Lilly & Company","url":"http:\/\/elil.ly\/communityguidelines","image":"https:\/\/pbs.twimg.com\/profile_images\/582648545926254592\/fzNfPMnV_normal.jpg","description":"An official Twitter feed of Eli Lilly and Company. LillyPad bloggers tweet on public policy, Life at Lilly and corporate responsibility.","id_on_source":"LillyPad","tweeter_id":"172496840","geo":{"lt":null,"ln":null},"followers":102865},"tweet_id":"871529513041231873"},{"url":"http:\/\/twitter.com\/DrKynast\/statuses\/871529909356769284","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T00:51:37+00:00","author":{"name":"Dr.med. Bernd Kynast","image":"https:\/\/pbs.twimg.com\/profile_images\/773512285629345792\/2AmdEU5W_normal.jpg","description":"Medical Oncology, Molecular Genetics, Medical & Business Consultancy, Commander (Navy, Reserve) \u00a7 Unfollow=blocked #Passion4America","id_on_source":"DrKynast","tweeter_id":"773340859303682049","geo":{"lt":null,"ln":null},"followers":2159},"tweet_id":"871529909356769284"},{"url":"http:\/\/twitter.com\/SamanthaHecht\/statuses\/871533335503413249","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T01:05:14+00:00","author":{"name":"Samantha Hecht","image":"https:\/\/pbs.twimg.com\/profile_images\/555577215711080450\/4FFiaePs_normal.jpeg","id_on_source":"SamanthaHecht","tweeter_id":"249946062","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":56},"tweet_id":"871533335503413249"},{"url":"http:\/\/twitter.com\/Massalcolombia\/statuses\/871548208740216832","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T02:04:20+00:00","author":{"name":"Alberto Cortes, MD","url":"http:\/\/www.massalcolombia.com","image":"https:\/\/pbs.twimg.com\/profile_images\/1580733481\/images_normal.jpeg","description":"Let's talk about Health systems, Health Care Financial Management, Leadership, Affordable Care Act, Public Health, and Social Determinants of Health","id_on_source":"Massalcolombia","tweeter_id":"387958397","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":144},"tweet_id":"871548208740216832"},{"url":"http:\/\/twitter.com\/CultPerfectMoms\/statuses\/871555375928983552","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T02:32:48+00:00","author":{"name":"Beth Caldwell","url":"http:\/\/cultofperfectmotherhood.com","image":"https:\/\/pbs.twimg.com\/profile_images\/871818022150823939\/_6rIQ1hb_normal.jpg","description":"Living with metastatic breast cancer since 2014; Deprogramming Women Since 2013; 2016 Democratic presidential elector; Co-founder, http:\/\/METUP.org","id_on_source":"CultPerfectMoms","tweeter_id":"2275168969","geo":{"lt":47.60621,"ln":-122.33207,"country":"US"},"followers":4314},"tweet_id":"871555375928983552"},{"url":"http:\/\/twitter.com\/Sorena997\/statuses\/871574808148017157","license":"gnip","rt":["oncoforecasting"],"citation_ids":[20798251],"posted_on":"2017-06-05T03:50:01+00:00","author":{"name":"Sorena","url":"http:\/\/www.cityofhope.org","image":"https:\/\/pbs.twimg.com\/profile_images\/820316132292726785\/r0ekzvEG_normal.jpg","description":"Chief-Informatics-Officer @cityofhope: Cancer & Diabetes Research\/Digital Health\/IT\/ *Informatics*\/OMICS\/Interoperability\/DataScience\/ PrecisionMedicine\/@ci4cc","id_on_source":"Sorena997","tweeter_id":"16195981","geo":{"lt":34.14778,"ln":-118.14452,"country":"US"},"followers":1645},"tweet_id":"871574808148017157"},{"url":"http:\/\/twitter.com\/Helen_Flint_\/statuses\/871605999324585984","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T05:53:58+00:00","author":{"name":"Helen Flint","image":"https:\/\/pbs.twimg.com\/profile_images\/1289286056\/Helen__a_warm_day_on_the_Bridge_normal.JPG","description":"evertonian, pharmacist","id_on_source":"Helen_Flint_","tweeter_id":"225849527","geo":{"lt":null,"ln":null},"followers":234},"tweet_id":"871605999324585984"},{"url":"http:\/\/twitter.com\/GlopesMd\/statuses\/871609310270324738","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-05T06:07:07+00:00","author":{"name":"gilberto lopes","url":"http:\/\/br.linkedin.com\/in\/drgilbertolopes","image":"https:\/\/pbs.twimg.com\/profile_images\/717018715343159296\/6XfyLguN_normal.jpg","description":"Cancer Doctor and Researcher, Faculty @SylvesterCancer @UnivMiami. Helping improve Cancer Control in Low and Middle Income Countries. COI on LinkedIn.","id_on_source":"GlopesMd","tweeter_id":"2183065733","geo":{"lt":25.77427,"ln":-80.19366,"country":"US"},"followers":21042},"tweet_id":"871609310270324738"},{"url":"http:\/\/twitter.com\/GlopesMd\/statuses\/871610220216295427","license":"gnip","rt":["GlopesMd"],"citation_ids":[20798251],"posted_on":"2017-06-05T06:10:44+00:00","author":{"name":"gilberto lopes","url":"http:\/\/br.linkedin.com\/in\/drgilbertolopes","image":"https:\/\/pbs.twimg.com\/profile_images\/717018715343159296\/6XfyLguN_normal.jpg","description":"Cancer Doctor and Researcher, Faculty @SylvesterCancer @UnivMiami. Helping improve Cancer Control in Low and Middle Income Countries. COI on LinkedIn.","id_on_source":"GlopesMd","tweeter_id":"2183065733","geo":{"lt":25.77427,"ln":-80.19366,"country":"US"},"followers":21042},"tweet_id":"871610220216295427"},{"url":"http:\/\/twitter.com\/DrShen_YY\/statuses\/871617798023335936","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T06:40:51+00:00","author":{"name":"Yuanyuan(Daisy) Shen","image":"https:\/\/pbs.twimg.com\/profile_images\/909249689937117185\/yqauZVH2_normal.jpg","description":"Medical Informatics Ph.D. Student @Mizzou Former Visiting Assistant Professor @YaleMed....General surgeon @Chongqing Medical University,China","id_on_source":"DrShen_YY","tweeter_id":"297096481","geo":{"lt":38.95171,"ln":-92.33407,"country":"US"},"followers":15},"tweet_id":"871617798023335936"},{"url":"http:\/\/twitter.com\/OncoHebdo\/statuses\/871643947344547840","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-05T08:24:46+00:00","author":{"name":"oncohebdo","url":"http:\/\/www.potentiel-daction.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/894454742734307328\/PuRo754l_normal.jpg","description":"Les informations cl\u00e9s de l'actualit\u00e9 en #oncologie : environnement sant\u00e9, pharma, innovation, mol\u00e9cules.","id_on_source":"OncoHebdo","tweeter_id":"837357028930633728","geo":{"lt":null,"ln":null},"followers":71},"tweet_id":"871643947344547840"},{"url":"http:\/\/twitter.com\/leninfapal\/statuses\/871699970637934593","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T12:07:23+00:00","author":{"name":"Lenin Palacios","image":"https:\/\/pbs.twimg.com\/profile_images\/838608727997571072\/i9hXUbam_normal.jpg","description":"Onc\u00f3logo Cl\u00ednico","id_on_source":"leninfapal","tweeter_id":"338983691","geo":{"lt":-3.99313,"ln":-79.20422,"country":"EC"},"followers":137},"tweet_id":"871699970637934593"},{"url":"http:\/\/twitter.com\/soniacuyer\/statuses\/871720935027507200","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T13:30:41+00:00","author":{"name":"soniacuyer\ud83c\udde6\ud83c\uddf7","image":"https:\/\/pbs.twimg.com\/profile_images\/644688263417085953\/zlgwMvWK_normal.jpg","description":"Medica ,clinica oncologica y urooncologia .Viajera incansable ,,,Bolivar","id_on_source":"soniacuyer","tweeter_id":"1317375612","geo":{"lt":-34,"ln":-64,"country":"AR"},"followers":328},"tweet_id":"871720935027507200"},{"url":"http:\/\/twitter.com\/NospmasD\/statuses\/871777197094313984","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-05T17:14:15+00:00","author":{"name":"David Sampson","image":"https:\/\/pbs.twimg.com\/profile_images\/701900787438510080\/fZCr7Apv_normal.jpg","description":"VP\/Publisher, Journals at American Society of Clinical Oncology, formerly at Elsevier and Wolters Kluwer Health, Opinions are my own","id_on_source":"NospmasD","tweeter_id":"704958478","geo":{"lt":38.50038,"ln":-80.50009,"country":"US"},"followers":184},"tweet_id":"871777197094313984"},{"url":"http:\/\/twitter.com\/NospmasD\/statuses\/871777841691717632","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-05T17:16:48+00:00","author":{"name":"David Sampson","image":"https:\/\/pbs.twimg.com\/profile_images\/701900787438510080\/fZCr7Apv_normal.jpg","description":"VP\/Publisher, Journals at American Society of Clinical Oncology, formerly at Elsevier and Wolters Kluwer Health, Opinions are my own","id_on_source":"NospmasD","tweeter_id":"704958478","geo":{"lt":38.50038,"ln":-80.50009,"country":"US"},"followers":184},"tweet_id":"871777841691717632"},{"url":"http:\/\/twitter.com\/RicevutoEnrico\/statuses\/871810689698066435","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T19:27:20+00:00","author":{"name":"Enrico Ricevuto","image":"https:\/\/pbs.twimg.com\/profile_images\/846044258188623874\/T_TdKnaP_normal.jpg","description":"Associate Professor Oncology, Chair Oncology Territorial Care, Oncology Network ASL1 Abruzzo, University of L'Aquila, Italy","id_on_source":"RicevutoEnrico","tweeter_id":"845227691544580096","geo":{"lt":null,"ln":null},"followers":21},"tweet_id":"871810689698066435"},{"url":"http:\/\/twitter.com\/desireeheadley\/statuses\/871827236734816256","license":"gnip","rt":["ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T20:33:05+00:00","author":{"name":"Desiree Headley","image":"https:\/\/pbs.twimg.com\/profile_images\/1214019456\/des3_normal.jpg","description":"I spend my days trying to find a cure for cancer and dreaming of traveling the world and playing golf.","id_on_source":"desireeheadley","tweeter_id":"230478065","geo":{"lt":null,"ln":null},"followers":55},"tweet_id":"871827236734816256"},{"url":"http:\/\/twitter.com\/desireeheadley\/statuses\/871827313805152256","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T20:33:24+00:00","author":{"name":"Desiree Headley","image":"https:\/\/pbs.twimg.com\/profile_images\/1214019456\/des3_normal.jpg","description":"I spend my days trying to find a cure for cancer and dreaming of traveling the world and playing golf.","id_on_source":"desireeheadley","tweeter_id":"230478065","geo":{"lt":null,"ln":null},"followers":55},"tweet_id":"871827313805152256"},{"url":"http:\/\/twitter.com\/ahonala\/statuses\/871829020844929025","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T20:40:11+00:00","author":{"name":"Jani Ahonala","image":"https:\/\/pbs.twimg.com\/profile_images\/611234580029382656\/peLhk8HP_normal.jpg","description":"Founder of @kaufmann and @noonahealthcare, My expertise includes design and digitalization of healthcare services\n#healthdesign, #digitalhealth #cancercare","id_on_source":"ahonala","tweeter_id":"392283924","geo":{"lt":null,"ln":null},"followers":272},"tweet_id":"871829020844929025"},{"url":"http:\/\/twitter.com\/JCO_ASCO\/statuses\/871861738131607554","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-05T22:50:11+00:00","author":{"name":"J Clinical Oncology","url":"http:\/\/JCO.org","image":"https:\/\/pbs.twimg.com\/profile_images\/715981880357683201\/8GMeAgKJ_normal.jpg","description":"Journal of Clinical Oncology is the authoritative resource for significant oncology research, published 3 times per month by @ASCO.","id_on_source":"JCO_ASCO","tweeter_id":"2395900849","geo":{"lt":null,"ln":null},"followers":6978},"tweet_id":"871861738131607554"},{"url":"http:\/\/twitter.com\/nycdoc29\/statuses\/871862810879434752","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T22:54:27+00:00","author":{"name":"NYCDoc29","image":"https:\/\/pbs.twimg.com\/profile_images\/1133269939\/image_normal.jpg","description":"ASCO Member, Hem\/Onc In 11 MD specialty private practice, former full time academic, traveller, foodie & out of necessity now a business person!","id_on_source":"nycdoc29","tweeter_id":"49415766","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":360},"tweet_id":"871862810879434752"},{"url":"http:\/\/twitter.com\/OncShahab\/statuses\/871863252791291904","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T22:56:12+00:00","author":{"name":"Nasir Shahab MD","image":"https:\/\/pbs.twimg.com\/profile_images\/870148743286358016\/HHfQT-DV_normal.jpg","description":"Oncology","id_on_source":"OncShahab","tweeter_id":"870144867057491969","geo":{"lt":41.78586,"ln":-88.14729,"country":"US"},"followers":2},"tweet_id":"871863252791291904"},{"url":"http:\/\/twitter.com\/lisamor2\/statuses\/871863957862182916","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T22:59:00+00:00","author":{"name":"Lisa M","image":"https:\/\/pbs.twimg.com\/profile_images\/871457703096463362\/rPyWjjLu_normal.jpg","description":"a thirty-something Melbournian working in cancer policy in the community sector; views my own","id_on_source":"lisamor2","tweeter_id":"342689478","geo":{"lt":null,"ln":null},"followers":129},"tweet_id":"871863957862182916"},{"url":"http:\/\/twitter.com\/MetastaticOdds\/statuses\/871870846486421505","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T23:26:23+00:00","author":{"name":"Theresa's Research","url":"http:\/\/theresasresearch.org","image":"https:\/\/pbs.twimg.com\/profile_images\/793495754434158593\/hL2u0ulI_normal.jpg","description":"Our mission is to specifically fund RESEARCH for metastatic breast cancer.\n\nWe host an annual medical conference for MBC.","id_on_source":"MetastaticOdds","tweeter_id":"1531633554","geo":{"lt":null,"ln":null},"followers":711},"tweet_id":"871870846486421505"},{"url":"http:\/\/twitter.com\/CI4CC\/statuses\/871874317067464705","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-05T23:40:10+00:00","author":{"name":"Cancer Informatics","url":"http:\/\/www.ci4cc.org","image":"https:\/\/pbs.twimg.com\/profile_images\/519531893985779714\/0hlCFW_p_normal.jpeg","description":"Cancer Informatics-for-Cancer Centers. Home for Health IT Pro's & NCI Designated Cancer Center Clinical, OMIC's, & Biomedical Informatics Academic Leaders","id_on_source":"CI4CC","tweeter_id":"1732599787","geo":{"lt":37.77493,"ln":-122.41942,"country":"US"},"followers":2586},"tweet_id":"871874317067464705"},{"url":"http:\/\/twitter.com\/VCCLibrary\/statuses\/871998215142486016","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-06T07:52:30+00:00","author":{"name":"Cancer Library VCC","url":"http:\/\/www.wales.nhs.uk\/velindrelibrary","image":"https:\/\/pbs.twimg.com\/profile_images\/478464349476884480\/YlBsicot_normal.jpeg","description":"The only cancer specialist library service in Wales.  Supporting NHS and academic staff, students and health professionals throughout the Principality.","id_on_source":"VCCLibrary","tweeter_id":"1288296943","geo":{"lt":51.48,"ln":-3.18,"country":"GB"},"followers":657},"tweet_id":"871998215142486016"},{"url":"http:\/\/twitter.com\/CancerWallonia\/statuses\/872000743716380674","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-06T08:02:32+00:00","author":{"name":"CancerWallonia","image":"https:\/\/pbs.twimg.com\/profile_images\/623178120615604224\/unGEOij0_normal.jpg","description":"Cancer: from Wallonia to the World, from the World to Wallonia -  Cancer: la Wallonie parle au Monde, le Monde parle \u00e0 la Wallonie","id_on_source":"CancerWallonia","tweeter_id":"2848852120","geo":{"lt":null,"ln":null},"followers":634},"tweet_id":"872000743716380674"},{"url":"http:\/\/twitter.com\/hoosierdfh\/statuses\/872076689098059777","license":"gnip","rt":["NospmasD"],"citation_ids":[20798251],"posted_on":"2017-06-06T13:04:19+00:00","author":{"name":"dan hayes","image":"https:\/\/pbs.twimg.com\/profile_images\/605099146064691200\/3VY92FvV_normal.jpg","description":"med oncologist at U. Michigan Cancer Center, husband, dad, sports fan; @ASCO president for 2016-2017 term. opinions are my own.","id_on_source":"hoosierdfh","tweeter_id":"1023316502","geo":{"lt":null,"ln":null},"followers":1455},"tweet_id":"872076689098059777"},{"url":"http:\/\/twitter.com\/DrHedrick\/statuses\/872076935710597120","license":"gnip","rt":["NospmasD"],"citation_ids":[20798251],"posted_on":"2017-06-06T13:05:18+00:00","author":{"name":"Dr Hedrick","image":"https:\/\/pbs.twimg.com\/profile_images\/910881992639737856\/4wb_Ic-a_normal.jpg","description":"Doc in Indy, IN. Tweets are my own, not medical advice, not affiliated with my employer.","id_on_source":"DrHedrick","tweeter_id":"192574681","geo":{"lt":39.76838,"ln":-86.15804,"country":"US"},"followers":1130},"tweet_id":"872076935710597120"},{"url":"http:\/\/twitter.com\/DrHBurstein\/statuses\/872080766141956096","license":"gnip","rt":["NospmasD"],"citation_ids":[20798251],"posted_on":"2017-06-06T13:20:31+00:00","author":{"name":"Hal Burstein, MD","url":"http:\/\/www.dana-farber.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/618868499423887360\/qUW4gRNl_normal.jpg","description":"Breast cancer specialist and scholar @DanaFarber Cancer Institute and @HarvardMed. Tweets are my own and not medical advice. #bcsm #mBCSM","id_on_source":"DrHBurstein","tweeter_id":"3366464453","geo":{"lt":42.35843,"ln":-71.05977,"country":"US"},"followers":2032},"tweet_id":"872080766141956096"},{"url":"http:\/\/twitter.com\/pam65230529\/statuses\/872099996623044615","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-06T14:36:56+00:00","author":{"name":"pamalmeida","image":"https:\/\/pbs.twimg.com\/profile_images\/611711837130854400\/mVLRb0Is_normal.jpg","id_on_source":"pam65230529","tweeter_id":"2979640456","geo":{"lt":null,"ln":null},"followers":22},"tweet_id":"872099996623044615"},{"url":"http:\/\/twitter.com\/CTruica\/statuses\/872116737034121217","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-06T15:43:27+00:00","author":{"name":"Cristina Truica","image":"https:\/\/pbs.twimg.com\/profile_images\/533359067788345344\/zIPLHW5K_normal.jpeg","id_on_source":"CTruica","tweeter_id":"403666423","geo":{"lt":null,"ln":null},"followers":78},"tweet_id":"872116737034121217"},{"url":"http:\/\/twitter.com\/DrChoueiri\/statuses\/872223236217589761","license":"gnip","rt":["NospmasD"],"citation_ids":[20798251],"posted_on":"2017-06-06T22:46:39+00:00","author":{"name":"Toni Choueiri, MD","url":"http:\/\/www.dana-farber.org","image":"https:\/\/pbs.twimg.com\/profile_images\/693093012025561088\/tgX3Norh_normal.jpg","description":"Director, GU Oncology @DanaFarber. Retweets\/\u2764 are not advice\/endorsements #kidneycancer #Harvard #GUcancr #prostatecancer #bladdercancer #ASCO","id_on_source":"DrChoueiri","tweeter_id":"4827883464","geo":{"lt":42.35843,"ln":-71.05977,"country":"US"},"followers":2642},"tweet_id":"872223236217589761"},{"url":"http:\/\/twitter.com\/onco_pedia\/statuses\/872228051605757952","license":"gnip","rt":["NospmasD"],"citation_ids":[20798251],"posted_on":"2017-06-06T23:05:47+00:00","author":{"name":"Oncopedia","url":"http:\/\/www.oncopedia.com.br","image":"https:\/\/pbs.twimg.com\/profile_images\/532584621079162880\/UtVdT_rP_normal.png","description":"Cancer news. Editor: Marcos Andr\u00e9 Costa, MD.  Oswaldo Cruz German Hospital, Sao Paolo - Brazil. Tweets are my own.","id_on_source":"onco_pedia","tweeter_id":"2842388747","geo":{"lt":null,"ln":null},"followers":594},"tweet_id":"872228051605757952"},{"url":"http:\/\/twitter.com\/Sorena997\/statuses\/872283386643185665","license":"gnip","rt":["NospmasD"],"citation_ids":[20798251],"posted_on":"2017-06-07T02:45:40+00:00","author":{"name":"Sorena","url":"http:\/\/www.cityofhope.org","image":"https:\/\/pbs.twimg.com\/profile_images\/820316132292726785\/r0ekzvEG_normal.jpg","description":"Chief-Informatics-Officer @cityofhope: Cancer & Diabetes Research\/Digital Health\/IT\/ *Informatics*\/OMICS\/Interoperability\/DataScience\/ PrecisionMedicine\/@ci4cc","id_on_source":"Sorena997","tweeter_id":"16195981","geo":{"lt":34.14778,"ln":-118.14452,"country":"US"},"followers":1645},"tweet_id":"872283386643185665"},{"url":"http:\/\/twitter.com\/FabioSchutz78\/statuses\/872509608526479361","license":"gnip","rt":["NospmasD"],"citation_ids":[20798251],"posted_on":"2017-06-07T17:44:35+00:00","author":{"name":"Fabio Schutz","image":"https:\/\/pbs.twimg.com\/profile_images\/870023146514132992\/p2bRqnx1_normal.jpg","description":"Medical oncologist at @BPorgbr. Former fellow of GU oncology @DanaFarber @Harvard @MOCbrasil. #GUcancer","id_on_source":"FabioSchutz78","tweeter_id":"870017969136467969","geo":{"lt":null,"ln":null},"followers":390},"tweet_id":"872509608526479361"},{"url":"http:\/\/twitter.com\/g_develasco\/statuses\/872513507790643200","license":"gnip","rt":["NospmasD"],"citation_ids":[20798251],"posted_on":"2017-06-07T18:00:05+00:00","author":{"name":"Guillermo de Velasco","image":"https:\/\/pbs.twimg.com\/profile_images\/604025451120607233\/c3ZxeUsb_normal.jpg","description":"Medical oncologist. 12deOctubre. #bladder #kidney #prostate #cancer","id_on_source":"g_develasco","tweeter_id":"600879761","geo":{"lt":null,"ln":null},"followers":1043},"tweet_id":"872513507790643200"},{"url":"http:\/\/twitter.com\/Pharma_Sharma\/statuses\/872521495536435201","license":"gnip","rt":["JCO_ASCO"],"citation_ids":[20798251],"posted_on":"2017-06-07T18:31:49+00:00","author":{"name":"Ravi Sharma","image":"https:\/\/pbs.twimg.com\/profile_images\/567910866587107328\/1GlDJtcy_normal.jpeg","description":"Biopharma, Biotech & Healthcare devotee w\/ 18+ yrs experience in sales, management & go-to-market strategy. Cross-pollinating minds, people & opportunities!","id_on_source":"Pharma_Sharma","tweeter_id":"3024792163","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":236},"tweet_id":"872521495536435201"},{"url":"http:\/\/twitter.com\/NatRevClinOncol\/statuses\/872872855968530432","license":"gnip","citation_ids":[20798251],"posted_on":"2017-06-08T17:48:00+00:00","author":{"name":"NatureRevClinOncol","url":"http:\/\/www.nature.com\/nrclinonc\/index.html","image":"https:\/\/pbs.twimg.com\/profile_images\/1587954262\/nrclinonc_Twitter_logo_normal.jpg","description":"The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.","id_on_source":"NatRevClinOncol","tweeter_id":"347276297","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":10546},"tweet_id":"872872855968530432"},{"url":"http:\/\/twitter.com\/Kev_Levine\/statuses\/872873862693875713","license":"gnip","rt":["NatRevClinOncol"],"citation_ids":[20798251],"posted_on":"2017-06-08T17:52:00+00:00","author":{"name":"Kevin Levine","image":"https:\/\/pbs.twimg.com\/profile_images\/707421013139529728\/3Omg1a6O_normal.jpg","id_on_source":"Kev_Levine","tweeter_id":"2402226097","geo":{"lt":null,"ln":null},"followers":49},"tweet_id":"872873862693875713"},{"url":"http:\/\/twitter.com\/urbano_anido\/statuses\/872878543524507648","license":"gnip","rt":["NatRevClinOncol"],"citation_ids":[20798251],"posted_on":"2017-06-08T18:10:36+00:00","author":{"name":"Urbano Anido","image":"https:\/\/pbs.twimg.com\/profile_images\/701328985590988800\/dFM9Y8VG_normal.jpg","description":"Father & husband | Scuba-diver | Medical oncologist | Own opinions & thoughts","id_on_source":"urbano_anido","tweeter_id":"2303944103","geo":{"lt":42.88052,"ln":-8.54569,"country":"ES"},"followers":453},"tweet_id":"872878543524507648"},{"url":"http:\/\/twitter.com\/srigsri23\/statuses\/872981038569463809","license":"gnip","rt":["NatRevClinOncol"],"citation_ids":[20798251],"posted_on":"2017-06-09T00:57:53+00:00","author":{"name":"Sriganesh Srihari","url":"http:\/\/member.acm.org\/~sriganeshs","image":"https:\/\/pbs.twimg.com\/profile_images\/663978064255168512\/1B-If9Gw_normal.jpg","description":"Senior Research Scientist, EMBL Australia; Adjunct Senior Lecturer, Flinders University","id_on_source":"srigsri23","tweeter_id":"4185121399","geo":{"lt":-34.92866,"ln":138.59863,"country":"AU"},"followers":94},"tweet_id":"872981038569463809"},{"url":"http:\/\/twitter.com\/CancerWallonia\/statuses\/873011343221288960","license":"gnip","rt":["NatRevClinOncol"],"citation_ids":[20798251],"posted_on":"2017-06-09T02:58:18+00:00","author":{"name":"CancerWallonia","image":"https:\/\/pbs.twimg.com\/profile_images\/623178120615604224\/unGEOij0_normal.jpg","description":"Cancer: from Wallonia to the World, from the World to Wallonia -  Cancer: la Wallonie parle au Monde, le Monde parle \u00e0 la Wallonie","id_on_source":"CancerWallonia","tweeter_id":"2848852120","geo":{"lt":null,"ln":null},"followers":634},"tweet_id":"873011343221288960"},{"url":"http:\/\/twitter.com\/markus_warmuth\/statuses\/873200713937162244","license":"gnip","rt":["NatRevClinOncol"],"citation_ids":[20798251],"posted_on":"2017-06-09T15:30:48+00:00","author":{"name":"Markus Warmuth","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"markus_warmuth","tweeter_id":"798055126799974400","geo":{"lt":null,"ln":null},"followers":13},"tweet_id":"873200713937162244"},{"url":"http:\/\/twitter.com\/oncologiaaf\/statuses\/881026379030179840","license":"gnip","citation_ids":[20798251],"posted_on":"2017-07-01T05:47:12+00:00","author":{"name":"Dr. Fernando Medina","url":"http:\/\/www.oncologia.com.br","image":"https:\/\/pbs.twimg.com\/profile_images\/895546008934985728\/5LVkh0zo_normal.jpg","description":"Oncologia Cl\u00ednico do Centro de Oncologia Campinas. Doutor em medicina pela UNICAMP. Fellow da Free  University Amsterdan.","id_on_source":"oncologiaaf","tweeter_id":"90207017","geo":{"lt":-22.90556,"ln":-47.06083,"country":"BR"},"followers":898},"tweet_id":"881026379030179840"},{"url":"http:\/\/twitter.com\/oncologiaaf\/statuses\/889663483389902851","license":"gnip","citation_ids":[20798251],"posted_on":"2017-07-25T01:47:58+00:00","author":{"name":"Dr. Fernando Medina","url":"http:\/\/www.oncologia.com.br","image":"https:\/\/pbs.twimg.com\/profile_images\/895546008934985728\/5LVkh0zo_normal.jpg","description":"Oncologia Cl\u00ednico do Centro de Oncologia Campinas. Doutor em medicina pela UNICAMP. Fellow da Free  University Amsterdan.","id_on_source":"oncologiaaf","tweeter_id":"90207017","geo":{"lt":-22.90556,"ln":-47.06083,"country":"BR"},"followers":898},"tweet_id":"889663483389902851"},{"url":"http:\/\/twitter.com\/DrRiadYounes\/statuses\/889803198692823041","license":"gnip","rt":["oncologiaaf"],"citation_ids":[20798251],"posted_on":"2017-07-25T11:03:08+00:00","author":{"name":"Riad Younes","image":"https:\/\/pbs.twimg.com\/profile_images\/829354159170281473\/aQIJ1SDL_normal.jpg","description":"Cirurgi\u00e3o, Diretor Geral do Centro Oncol\u00f3gico do Hospital Alem\u00e3o Oswaldo Cruz","id_on_source":"DrRiadYounes","tweeter_id":"828239815430774784","geo":{"lt":-23.5475,"ln":-46.63611,"country":"BR"},"followers":211},"tweet_id":"889803198692823041"},{"url":"http:\/\/twitter.com\/RicardoCaponero\/statuses\/889839981455450115","license":"gnip","rt":["oncologiaaf"],"citation_ids":[20798251],"posted_on":"2017-07-25T13:29:18+00:00","author":{"name":"Ricardo Caponero","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"RicardoCaponero","tweeter_id":"832628756309086209","geo":{"lt":null,"ln":null},"followers":41},"tweet_id":"889839981455450115"},{"url":"http:\/\/twitter.com\/MOCBrasil\/statuses\/904002214838108160","license":"gnip","citation_ids":[20798251],"posted_on":"2017-09-02T15:24:58+00:00","author":{"name":"MOC Brasil","url":"http:\/\/mocbrasil.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/862632098729009152\/WHbfcIae_normal.jpg","description":"Manual de Oncologia Cl\u00ednica do Brasil\r\nDescri\u00e7\u00e3o\r\nO MOC \u2013 Manual de Oncologia Cl\u00ednica do Brasil \u00e9 considerado uma refer\u00eancia em Oncologia.","id_on_source":"MOCBrasil","tweeter_id":"1877479718","geo":{"lt":-23.5475,"ln":-46.63611,"country":"BR"},"followers":559},"tweet_id":"904002214838108160"},{"url":"http:\/\/twitter.com\/fmedinacunha\/statuses\/904017596068106240","license":"gnip","rt":["MOCBrasil"],"citation_ids":[20798251],"posted_on":"2017-09-02T16:26:05+00:00","author":{"name":"Fernando Medina","url":"http:\/\/www.oncologia.com.br","image":"https:\/\/pbs.twimg.com\/profile_images\/869486813358022656\/oJ_lULIb_normal.jpg","description":"Oncologista, doutor em medicina pela Universidade de Campinas e Free university,  Amsterdan,  Holanda.","id_on_source":"fmedinacunha","tweeter_id":"53357369","geo":{"lt":-22.90556,"ln":-47.06083,"country":"BR"},"followers":182},"tweet_id":"904017596068106240"}],"facebook":[{"title":"MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+\/HER2\u2212 Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy: Journal of Clinical Oncology: Vol 0, No 0","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1085374868261080&id=458120690986504","license":"public","citation_ids":[20798251],"posted_on":"2017-06-05T10:33:21+00:00","summary":"MONARCH 2 \u8a66\u9a13\u3002CDK4\/6\u963b\u5bb3\u5264 abemaciclib \u3068 fulvestrant \u306e\u4f75\u7528\u306f\u3001\u4e00\u6b21\u30db\u30eb\u30e2\u30f3\u7642\u6cd5\u8010\u6027\u3068\u306a\u3063\u305f\u30db\u30eb\u30e2\u30f3\u30ec\u30bb\u30d7\u30bf\u30fc\u967d\u6027 \/ HER2\u9670\u6027\u9032\u884c\u4e73\u304c\u3093\u306e progression-free survival \u3092\u5ef6\u9577\u3059\u308b (\u6587\u732e2017-111)\u3002\n\n\"MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+\/HER2\u2212 Advanced Breast Cancer Who Had Pro","author":{"name":"\u5cb8\u548c\u7530\u5e02\u4e73\u817a\u5916\u79d1\u5c02\u9580\u533b\u306e\u30da\u30fc\u30b8","url":"https:\/\/www.facebook.com\/458120690986504","facebook_wall_name":"\u5cb8\u548c\u7530\u5e02\u4e73\u817a\u5916\u79d1\u5c02\u9580\u533b\u306e\u30da\u30fc\u30b8","image":"https:\/\/graph.facebook.com\/458120690986504\/picture","id_on_source":"458120690986504"}},{"title":"MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR \/HER2\u2212 Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy: Journal of Clinical Oncology: Vol 0, No 0","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=825785437575563&id=134779230009524","license":"public","citation_ids":[20798251],"posted_on":"2017-06-06T01:41:11+00:00","summary":"Abemaciclib at 150 mg twice daily plus fulvestrant was effective, significantly improving progression-free survival and objective response rate and demonstrating a tolerable safety profile in women with hormone receptor-positive and human epidermal growth","author":{"name":"Thai Breast Disease Society","url":"https:\/\/www.facebook.com\/134779230009524","facebook_wall_name":"Thai Breast Disease Society","image":"https:\/\/graph.facebook.com\/134779230009524\/picture","id_on_source":"134779230009524"}}]}}